Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma

This study has been completed.
University of Chicago
Columbia University
Information provided by:
University of Texas Southwestern Medical Center Identifier:
First received: February 22, 2006
Last updated: August 16, 2010
Last verified: February 2006
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2010
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)